Case Study: Novartis cuts managed access turnaround time from five days to five hours with Bonterra

Novartis slashes managed access turnaround time from five days to five hours with Bonterra

Novartis faced a rapid influx of managed access requests for COVID-19 treatments during the pandemic and needed to accelerate its workflows to expedite drug delivery. The company partnered with Bonterra to address this challenge and eliminate bottlenecks in the review and approval process.

Working with Bonterra, Novartis identified and removed key inefficiencies in its system. This implementation dramatically reduced the managed access turnaround time from five days to just five hours, significantly accelerating the delivery of treatments to critically ill patients.

Novartis